Award
Delivery Order #SPE2DR26FKKV2
Delivery Order for Xolair Autoinjectors to DMS Pharmaceutical Group
Buyer
Defense Logistics Agency
Award Amount
$873.72
Ceiling
$873.72
Awarded
February 26, 2026
Period of Performance
Feb 26, 2026 – Mar 19, 2026
Identifier
SPE2DR26FKKV2
NAICS
424210
This award is a delivery order contract awarded to DMS Pharmaceutical Group Inc., a company specializing in pharmaceutical supply, under a broader Indefinite Delivery Vehicle contract focused on essential drug provision. The contract involves procuring Xolair 150 MG/ML autoinjectors, critical medication used in treatment protocols, emphasizing the agency's commitment to maintaining a reliable pharmaceutical supply chain. The delivery order ensures timely supply within a short, fixed timeframe, supporting ongoing healthcare needs. It was competitively sourced through a pre-existing IDV framework, enhancing procurement efficiency. The performance period is brief and specific, spanning a few weeks in early 2026, reflecting precise and urgent medical supply requirements. This contract is integral to sustaining public health initiatives by facilitating rapid access to essential drugs.
Description
4571043152!XOLAIR 150 MG/ML AUTOINJECTORML